Universal Health (UHS) Stock Forecast & Price Target

Compare

533 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

UHS Analyst Ratings

Moderate Buy

8 Buy

7 Hold

1 Sell

Based on 16 analysts giving stock ratings to

Universal

Health

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

UHS Stock 12 Month Forecast

Average Price Target

$245.29

▲(8.35% Upside)

Based on 16 Wall Street analysts offering 12 month price targets for Universal Health in the last 3 months. The average price target is $245.29 with a high forecast of $302.00 and a low forecast of $190.00. The average price target represents a 8.35% change from the last price of $226.39.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"161":"$161","232":"$232","303":"$303","196.5":"$196.5","267.5":"$267.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":302,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$302.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":245.29,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$245.29</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":190,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$190.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[161,196.5,232,267.5,303],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2025","6":"May<br/>2025","9":"Aug<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,217.01,223.5476923076923,230.0853846153846,236.62307692307692,243.16076923076923,249.69846153846154,256.23615384615385,262.77384615384614,269.3115384615385,275.84923076923076,282.3869230769231,288.9246153846154,295.4623076923077,{"y":302,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,217.01,219.1853846153846,221.36076923076922,223.53615384615384,225.71153846153845,227.88692307692307,230.06230769230768,232.2376923076923,234.41307692307691,236.58846153846153,238.76384615384615,240.93923076923076,243.11461538461538,{"y":245.29,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,217.01,214.9323076923077,212.85461538461539,210.77692307692308,208.69923076923075,206.62153846153845,204.54384615384615,202.46615384615384,200.38846153846154,198.31076923076924,196.2330769230769,194.1553846153846,192.0776923076923,{"y":190,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":204.38,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":200.2,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":178.83,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":187.94,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":174.67,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":187.41,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":174.25,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":187.17,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":188.73,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":162.8,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":181.51,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":203.51,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":217.01,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$302.00

Average Price Target$245.29

Lowest Price Target$190.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Ann Hynes

Mizuho Securities

$242→$267

Buy

17.94%

Upside

Reiterated

11/03/25

Universal Health price target raised to $267 from $242 at MizuhoUniversal Health price target raised to $267 from $242 at Mizuho

John Ransom

Raymond James

$270

Buy

19.26%

Upside

Upgraded

11/03/25

Universal Health upgraded to Outperform from Market Perform at Raymond JamesUniversal Health upgraded to Outperform from Market Perform at Raymond James

Ben Hendrix

RBC Capital

$206→$231

Hold

2.04%

Upside

Reiterated

10/30/25

Universal Health (UHS) Receives a Hold from RBC Capital

A.J. Rice

UBS

$280→$302

Buy

33.40%

Upside

Reiterated

10/29/25

Universal Health price target raised to $302 from $280 at UBSUniversal Health price target raised to $302 from $280 at UBS

Craig Hettenbach

Morgan Stanley

$200→$233

Hold

2.92%

Upside

Reiterated

10/29/25

Universal Health's Mixed Q3 Performance and Stable Outlook Justify Hold Rating

Benjamin Rossi

J.P. Morgan

―

Hold

―

Reiterated

10/29/25

Universal Health: Balanced Outlook Amid MSPP Gains and Medicaid Challenges

Ryan Langston

TD Cowen

$227→$251

Buy

10.87%

Upside

Reiterated

10/29/25

Universal Health Services: Strong Growth and Strategic Expansion Drive Buy Rating with $251 Price Target

Kevin Fischbeck

Bank of America Securities

$165→$190

Sell

-16.07%

Downside

Reiterated

10/28/25

Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (NASDAQ: BMRN) and Universal Health (NYSE: UHS)

Matthew Gillmor CFA

KeyBanc

―

Hold

―

Reiterated

10/28/25

KeyBanc Remains a Hold on Universal Health (UHS)

Rosa Clinessa

TR | OpenAI - 4o

$235→$243

Buy

7.34%

Upside

Reiterated

10/28/25

AI Generated ArticleAI Generated Article

Jason Cassorla

Guggenheim

$227→$253

Buy

11.75%

Upside

Reiterated

10/28/25

Universal Health price target raised to $253 from $227 at GuggenheimUniversal Health price target raised to $253 from $227 at Guggenheim

Sarah James

Cantor Fitzgerald

$227

Hold

0.27%

Upside

Reiterated

10/27/25

Cantor Fitzgerald Reaffirms Their Hold Rating on Universal Health (UHS)

Andrew Mok CFA

Barclays

$250→$263

Buy

16.17%

Upside

Reiterated

10/27/25

Barclays Keeps Their Buy Rating on Universal Health (UHS)

Whit Mayo

Leerink Partners

$276

Buy

21.91%

Upside

Reiterated

10/22/25

Leerink Partners Keeps Their Buy Rating on Universal Health (UHS)

Scott Fidel

Goldman Sachs

$180→$219

Hold

-3.26%

Downside

Reiterated

10/15/25

Goldman Sachs Sticks to Their Hold Rating for Universal Health (UHS)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Ann Hynes

Mizuho Securities

$242→$267

Buy

17.94%

Upside

Reiterated

11/03/25

Universal Health price target raised to $267 from $242 at MizuhoUniversal Health price target raised to $267 from $242 at Mizuho

John Ransom

Raymond James

$270

Buy

19.26%

Upside

Upgraded

11/03/25

Universal Health upgraded to Outperform from Market Perform at Raymond JamesUniversal Health upgraded to Outperform from Market Perform at Raymond James

Ben Hendrix

RBC Capital

$206→$231

Hold

2.04%

Upside

Reiterated

10/30/25

Universal Health (UHS) Receives a Hold from RBC Capital

A.J. Rice

UBS

$280→$302

Buy

33.40%

Upside

Reiterated

10/29/25

Universal Health price target raised to $302 from $280 at UBSUniversal Health price target raised to $302 from $280 at UBS

Craig Hettenbach

Morgan Stanley

$200→$233

Hold

2.92%

Upside

Reiterated

10/29/25

Universal Health's Mixed Q3 Performance and Stable Outlook Justify Hold Rating

Benjamin Rossi

J.P. Morgan

―

Hold

―

Reiterated

10/29/25

Universal Health: Balanced Outlook Amid MSPP Gains and Medicaid Challenges

Ryan Langston

TD Cowen

$227→$251

Buy

10.87%

Upside

Reiterated

10/29/25

Universal Health Services: Strong Growth and Strategic Expansion Drive Buy Rating with $251 Price Target

Kevin Fischbeck

Bank of America Securities

$165→$190

Sell

-16.07%

Downside

Reiterated

10/28/25

Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (NASDAQ: BMRN) and Universal Health (NYSE: UHS)

Matthew Gillmor CFA

KeyBanc

―

Hold

―

Reiterated

10/28/25

KeyBanc Remains a Hold on Universal Health (UHS)

Rosa Clinessa

TR | OpenAI - 4o

$235→$243

Buy

7.34%

Upside

Reiterated

10/28/25

AI Generated ArticleAI Generated Article

Jason Cassorla

Guggenheim

$227→$253

Buy

11.75%

Upside

Reiterated

10/28/25

Universal Health price target raised to $253 from $227 at GuggenheimUniversal Health price target raised to $253 from $227 at Guggenheim

Sarah James

Cantor Fitzgerald

$227

Hold

0.27%

Upside

Reiterated

10/27/25

Cantor Fitzgerald Reaffirms Their Hold Rating on Universal Health (UHS)

Andrew Mok CFA

Barclays

$250→$263

Buy

16.17%

Upside

Reiterated

10/27/25

Barclays Keeps Their Buy Rating on Universal Health (UHS)

Whit Mayo

Leerink Partners

$276

Buy

21.91%

Upside

Reiterated

10/22/25

Leerink Partners Keeps Their Buy Rating on Universal Health (UHS)

Scott Fidel

Goldman Sachs

$180→$219

Hold

-3.26%

Downside

Reiterated

10/15/25

Goldman Sachs Sticks to Their Hold Rating for Universal Health (UHS)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Universal Health

1 Month

xxx

Success Rate

13/18 ratings generated profit

Average Return

+3.92%

reiterated a xxx

rating 11 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 72.22% of your transactions generating a profit, with an average return of +3.92% per trade.

3 Months

xxx

Success Rate

21/31 ratings generated profit

Average Return

+4.32%

reiterated a xxx

rating 17 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 67.74% of your transactions generating a profit, with an average return of +4.32% per trade.

1 Year

Kevin FischbeckBank of America Securities

Success Rate

13/18 ratings generated profit

Average Return

+11.82%

reiterated a sell rating 11 days ago

Copying Kevin Fischbeck's trades and holding each position for 1 Year would result in 72.22% of your transactions generating a profit, with an average return of +11.82% per trade.

2 Years

xxx

Success Rate

24/28 ratings generated profit

Average Return

+27.27%

reiterated a xxx

rating 5 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 85.71% of your transactions generating a profit, with an average return of +27.27% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

UHS Analyst Recommendation Trends

Rating

Jul 25

Aug 25

Sep 25

Oct 25

Nov 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, UHS has received 18 Buy Ratings, 10 Hold Ratings, and 1 Sell Ratings. UHS average Analyst price target in the past 3 months is 245.29.

Each month's total comprises the sum of three months' worth of ratings.

UHS Financial Forecast

UHS Earnings Forecast

Next quarter’s earnings estimate for UHS is $5.88 with a range of $5.62 to $6.14. The previous quarter’s EPS was $5.69. UHS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year UHS has Preformed in-line its overall industry.

UHS Sales Forecast

Next quarter’s sales forecast for UHS is $4.50B with a range of $4.45B to $4.57B. The previous quarter’s sales results were $4.50B. UHS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year UHS has Preformed in-line its overall industry.

UHS Stock Forecast FAQ

What is UHS’s average 12-month price target, according to analysts?

Based on analyst ratings, Universal Health’s 12-month average price target is 245.29.

What is UHS’s upside potential, based on the analysts’ average price target?

Universal Health has 8.35% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is UHS a Buy, Sell or Hold?

Universal Health has a consensus rating of Moderate Buy which is based on 8 buy ratings, 7 hold ratings and 1 sell ratings.

What is Universal Health’s price target?

The average price target for Universal Health is 245.29. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $302.00 ,the lowest forecast is $190.00. The average price target represents 8.35% Increase from the current price of $226.39.

What do analysts say about Universal Health?

Universal Health’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 16 Wall Streets Analysts.

How can I buy shares of UHS?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Universal Health (UHS) Stock Forecast & Price Target

UHS Analyst Ratings

UHS Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Universal Health

UHS Analyst Recommendation Trends

UHS Financial Forecast

UHS Earnings Forecast

UHS Sales Forecast

UHS Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts